Generally, viral infections activate the immune system, which generates large numbers of immune cells, cytokines, and other effectors that are needed to terminate the infection by eradicating infected cells and virus [1] . This initial expansion stage is followed by a contraction
stage, during which, it is currently thought, regulatory T (T reg ) cells play a prominent role in maintaining the delicate balance between an immune response that is sufficiently robust to clear the infection and the immunopathological consequences of sustained immune activation and inflammation [2, 3] .
Similarly, during the early stages of HIV and simian immunodeficiency virus (SIV) infection, viral replication in lymphatic tissue activates the immune system, and viral levels decrease in concert with increasing numbers of virus-specific cytotoxic T lymphocytes (CTLs) [4, 5] . However, HIV and SIV infections are typically persistent, with viral replication continuing because of the incomplete clearance of productively infected cells. Among the many mechanisms that contribute to the inability of CTLs to eliminate all of the productively infected cells, there is increasing evidence (particularly from the SIV-infected rhesus macaque [RM] model) indicating that the CTL response is too little, too late [6, 7] . Because several studies have shown that the magnitude of effector T cell immune responses to acute viral infections can be limited by T reg cells [8] [9] [10] , and because T reg cells may enable some pathogens to establish chronic infection by blunting the immune response, we hypothesized that an immunosuppressive T reg cell response might be one mechanism that delays and limits the CTL response during acute lentiviral infection, resulting in virus-specific responses of insufficient magnitude to clear these infections. In this hypothesis, the immunosuppressive T reg cell response is untimely or premature in that it kicks in to regulate the massive immune activation and inflammation in lymphatic tissue so quickly that it dampens the CTL response before infected cells have been completely eliminated. We tested this hypothesis using the SIV-infected RM model, in which we could examine, during the acute stage of infection, the relationship between viral replication and immune defense and immunoregulatory responses. We show that, in lymphatic tissue, T reg cells and immunosuppressive mediators are induced so early in response to immune activation that SIV-specific CTL responses are constrained at just the time when they are most needed to clear the infection.
MATERIALS AND METHODS

Animals and experimental SIV and rhesus cytomegalovirus (RhCMV) infections.
To characterize the early T reg cell response in lymphatic tissue, we studied tissues from 3 different experiments in SIV-infected RMs and from a separate study of primary RhCMV infection. In the first study, lymph node (LN) tissues were obtained at necropsy from 4 adult female Indian RMs 1-12 days after atraumatic intravaginal (ivag) infection, as described elsewhere [11] . In the second study, LN tissues were obtained at necropsy from 5 adult female RMs 2 h-28 days after ivag inoculation of TCID 50 of SIV mac251 or 5 2 ϫ 10 SIV mac239 [12] . In the third study, which was longitudinal, LN biopsy samples were obtained from 4 adult female RMs before and 7 and 28 days after intravenous (iv) infusion of 1 MID 50 of SIV mac239 .
In the fourth study, 4 CMV-negative juvenile RMs were subcutaneously inoculated with pfu of CMV strain 68.1 at 6 1 ϫ 10 2 sites. LN biopsy samples were obtained 21 days before and 7, 14 (2 RMs), 28 (2 RMs), and 70 days after infection. Tissues were snap-frozen in liquid nitrogen and embedded in OTC for long-term storage. All animal studies were approved by the appropriate institutional review board.
Immunohistochemical staining, in situ hybridization, quantitative image analysis, and tetramer staining. Single immunohistochemical staining, in situ hybridization, and quantitative image analysis were performed as described elsewhere [11, 13] . Antibodies used were rabbit and goat anti-transforming growth factor (TGF)-b1, goat anti-FOXP3, mouse and rabbit anti-interleukin (IL)-10 (all from Santa Cruz Biotech), rabbit anti-FOXP3 (gift from A. Y. Rudensky, M. A. Gavin, and P. deRoos, Howard Hughes Medical Institute, University of Washington), rabbit anti-CD3 (DakoCytomation), mouse antiindoleamine 2,3-dioxygenase (IDO; Chemicon International), mouse anti-CD4 (Novocastra Laboratories), and mouse anti-CD25 (NeoMarkers). Anti-FOXP3 (Santa Cruz Biotech) specificity was determined by incubating the antibody with the FOXP3 peptide used as the immunogen at a peptide:antibody ratio of 20:1 before incubation with tissue sections. Although the peptide-blocking treatment did not completely abrogate FOXP3 staining in all tissue samples, it did dramatically reduce the detection of FOXP3 by use of antibody (data not shown). Dual-label immunofluorescence confocal microscopy was performed as described elsewhere [13] . Tetramer analysis on CTLs from lymphatic tissue was performed as described elsewhere [14] .
Statistical methods. For quantitative image-analysis data, the mean for each RM was derived from at least 18 randomly acquired high-power images. The graphs show either individual means (for groups with ) or group means (derived by n p 1 averaging all individual RM ). To assess increases means ‫ע‬ SEs in the frequency of TGF-b1 + and FOXP3 + cells during infection, we fit linear models for each protein, pooling all of the data from the RMs into 1 model. Linearity was assessed graphically for those RMs with multiple measurements and was also more formally assessed by incorporating a quadratic term in the models; both of these strategies suggested that the linearity of change over time was reasonable. In a linear model that allowed for correlation within measurements from the same RM, model parameters were estimated using maximum likelihood (using S-plus [version 3.1, release 1], a statistical program from MathSoft). To test whether the magnitude of the responses was increasing, we conducted a hypothesis test on the slope parameter in the linear model. This test indicated that the changes observed for both TGF-b1 + cells and FOXP3 + cells were statistically significant ( , for both). To test for an asso-P ! .0001 ciation between the frequency of T reg cells and the percentage of SL8 tetramer + CD8 + T cells, a random-effects model was used (using restricted maximum likelihood, as implemented in the varcomp function in S-plus). This model allows for testing an association when multiple measurements are taken from individual subjects and one wants to combine these measurements. This model was also used to investigate the effect of LN location on the association; however, because no such effect was found, the data were aggregated.
RESULTS
In recent experiments investigating the CTL response to SIV after ivag infection, we found that the response to immunodominant epitopes in SIV was too late in the sense that it was not detectable until several days after the peak of virus replication in lymphatic + cells (upper panels) in the paracortical T cell zones of secondary lymphatic tissue shortly after both intravenous (iv) and intravaginal (ivag) SIV infection (TGF-b1 + cells are indicated by brown staining; original magnification, ϫ400). Productively infected cells (lower panels) were detected by in situ hybridization within 7 days of iv infection, and the level peaked at 28 days after iv infection, whereas the level of productively infected cells peaked at 12 days and remained high until 21 days after ivag infection (original magnification, ϫ100). B, Enumeration of the frequency of TGF-b1 + cells. TGF-b1 + cells were enumerated in at least 18 randomly acquired high-power images for each RM, and the graphs show either individual means (for groups with ) or group means (derived n p 1 by averaging all individual RM ); the no. of RMs at each time point is shown in parentheses. To determine whether the increase in TGFmeans ‫ע‬ SEs b1 expression was statistically significant over time, the data were fit into a model that incorporated data from all RMs and time points, as outlined in Materials and Methods. This model indicated that the change observed for TGF-b1 expression was statistically significant ( ). P ! .0001 + T reg cells. The frequency of FOXP3 + T reg cells was determined and plotted as described in figure 1. To determine whether the increase in FOXP3 expression was statistically significant over time, the data were fit into a model that incorporated data from all RMs and time points, as outlined in Materials and Methods. This model indicated that the change observed for FOXP3 expression was statistically significant ( ). P ! .0001 tissue [7] . Moreover, the response was too little in the sense that the number of SIV-specific CTLs decreased from peak levels even while productively infected cells remained in lymphatic tissue. To investigate the possibility that one reason for the failure to clear infection was an early immunosuppressive response that prematurely limited the immune response before the infection had been cleared, we examined lymphatic tissue obtained during acute SIV infection, to evaluate the relationship that might exist between the timing and magnitude of immunosuppressive responses and viral replication.
Induction of TGF-b1 + cells during acute SIV infection. We began by assaying TGF-b1, a potent immunosuppressive soluble mediator and major effector molecule used by CD4 + CD25 + T reg cells. Analyzing the period from the onset of viral replication in lymphatic tissue (∼7 days after infection), through the peak (10-14 days) and subsequent decrease of replication, and to the time of persistent infection (28 days), during which sustained levels of replication are characteristic [12] , we quantified TGF-b1 expression in pooled LN biopsy samples from separate studies of acute infection after inoculation of SIV by iv and ivag routes.
In LN samples obtained sequentially from the same RMs that had been iv infected, there were few TGF-b1 + cells before infection, but, by 7 days after infection, the frequencies of TGFb1 + cells in the paracortical T cell zones had increased 14-fold, and, by 28 days after infection, they had increased 111-fold ( figure 1A and 1B) . There was a similar rapid increase in LN samples obtained at necropsy from RMs 12, 14, and 21 days after ivag infection-the frequencies of TGF-b1 + cells were 110-fold higher in infected RMs than in uninfected control RMs ( figure 1A and 1B) .
The rapidity of the TGF-b1 response was consistent with the hypothesis that the early peak of viral replication was driving this immunoregulatory response. Indeed, we found that the peak of the TGF-b1 response occurred soon after the peak of virus replication, from days 10 to 14. More importantly, the frequency of TGF-b1 + cells remained high when there were still significant numbers of productively infected cells in lymphatic tissue (figure 1A, lower panels), a finding that is consistent with the hypothesis that this immunosuppressive response is premature with respect to the host defense's attempt to eradicate the infection.
Induction of CD4 + CD25 + FOXP3 + T reg cells during acute SIV infection. We next established that the TGF-b1 response is just one manifestation of an early general immunosuppressive response composed of T reg cells and potent immunosuppressive mediators. We quantified the T reg cell response by staining tissue sections for the transcription factor that controls the generation of natural T reg cells, FOXP3 [15, 16] , and for CD4 and CD25. The majority of the FOXP3 + cells (mean ‫ע‬ SD, 93.4% ‫ע‬ 4.2%) that accumulated rapidly in the paracortical T cell zones of secondary lymphatic tissue shortly after SIV infection were CD4 + CD25
+ T reg cells ( figure 2A ). In addition, we found that most of the TGF-b1 + cells (mean ‫ע‬ SD, 76.2% ‫ע‬ ) also coexpressed FOXP3 and were CD4 + CD25
+ T reg cells 16.7% ( figure 2A and table 1) , with the rest presumably being Th3 cells. Importantly, the increased frequency of FOXP3 + T reg cells in secondary lymphatic tissue ( figure 2B and 2C ) was approximately equal to the increased frequency of TGF-b1 + cells. Because human T reg cells are highly susceptible to HIV infection in vitro [17] , we reasoned that the dramatic increase in the frequency of T reg cells reported here could provide a highly susceptible population of target cells for further SIV propagation, and we investigated the possibility that the increase in the frequency of T reg cells was limited by productive infection. Surprisingly, at the peak of viral replication (10-14 days after infection), we found that, on average, only 13% of figure  3A) . We found that the frequency of IL-10 + cells increased as early as 7 days after infection with a dramatic increase by 28 days, which was similar in magnitude and timing to the increased frequency of TGF-b1 + cells and FOXP3 + T reg cells. Moreover, we also found increased frequencies of cells expressing IDO (figure 3B), an interferon (IFN)-g inducible enzyme that generates such highly immunosuppressive byproducts as n-formylkynurenine by oxidative degradation of tryptophan. We suspected that tolerogenic dendritic cells (DCs) might be the source of the IDO, on the basis of the study by Munn et al. demonstrating the existence of a subset of monocyte-derived DCs that use this enzyme to suppress T cell proliferation in vitro [18] . However, we found that, during acute SIV infection, most of the IDO + cells were CD3 + T cells ( figure  3B) 
Kinetics of induction of T reg cells parallel kinetics of immune activation but differ during SIV and RhCMV infection.
We hypothesized that the immune activation that accompanied viral replication in SIV-infected LNs was driving the early induction of the immunosuppressive response, and we tested this hypothesis in 2 ways: (1) by characterizing the relationship between the kinetics of the induction of T reg cells and the kinetics of immune activation during SIV infection and (2) by comparing this relationship with that for infection with another virus, RhCMV, during which immune activation occurs later and in response to antigenic stimulation only, rather than to the combined effect of antigenic stimulation and viral infection in lymphatic tissue, as is the case for SIV. Consistent with this model indicates that the weaker relationship we observed between the frequency of SIV RNA + cells and the frequency of T reg cells reflects the stronger association between the frequency of T reg cells and the magnitude of immune activation and the relationship between the magnitude of immune activation and the level of SIV infection. We think that these data support the hypothesis that viral replication indirectly drives the induction of T reg cells by inducing a massive state of immune activation.
In contrast, in the RhCMV-infected RMs, immune activation within the paracortical T cell zones was not evident until 70 days after infection, and the peak T reg cell response was correspondingly delayed and of lower magnitude ( figure 4C ). Immune activation in the RhCMV-infected RMs likely occurred in response to persistent systemic infection at other anatomic sites, because we did not detect any IE-1 + (immediate early-1 gene product) or pp65 + (matrix phosphoprotein-65 late gene product) productively RhCMV-infected cells in the LN samples by immunohistochemistry or sensitive polymerase chain reaction techniques (data not shown). Thus, for both infections, immune activation is correlated with a counterbalancing T reg cell response, but the timing is different. Most importantly, the replication-driven immune activation that occurs early during SIV infection induces a rapid T reg cell response that has the potential to negatively impact the host cellular immune response to infection while replication continues.
Impact of T reg cells on the CTL response during acute SIV infection. To test the hypothesis that the early induction of the T reg cell response to counter immune activation and inflammation in SIV-infected lymphatic tissues might, in fact, detrimentally affect SIV-specific immune responses, we compared the frequency of FOXP3 + T reg cells to the percentage of SIV-specific CTLs that recognized SL8 (aa 28-35), an immunodominant epitope in Tat that has been shown to exert strong selective pressure on SIV (figure 5) [19] . We quantified the SL8 Figure 5 . Significant inverse correlation between the frequency of FOXP3 + regulatory T (T reg ) cells and the magnitude of the cytotoxic T lymphocyte (CTL) response to the Tat immunodominant epitope SL8. Tetramer analysis was performed on CTLs that had been isolated from a portion of the obturator (circles), inguinal (squares), and mesenteric (triangles) lymph nodes (LNs) from 5 Mamu-A*01 major histocompatibility complex class I allele-positive rhesus macaques (21-28 days after infection). The frequency of T reg cells was determined on the basis of tissue sections from the same LNs, as described in Materials and Methods. The relationship was highly significant ( ), as determined on the P ! .01 basis of a test of the regression slope in a random effects model, which is described in detail in Materials and Methods.
tetramer
+ CD8 + T cell responses in 5 Mamu-A*01 major histocompatibility complex class I allele-positive RMs, and we detected significant percentages (1.25%-4.61%) of SL8 tetramer + CD8
+ T cells in 2 of them (RM 1919 and RM 27099). In contrast, the SL8 responses were low (0.01%-0.8%) or undetectable in the other 3 RMs. There was a significant inverse correlation between the frequency of T reg cells and the percentage of SL8 tetramer + CD8
+ T cells at 21 and 28 days after infection ( ; ) (figure 5), which is consistent with the r p Ϫ0.812 P ! .01 idea that T reg cells inhibit the CTL response to the immunodominant epitope SL8, which has been shown to play such an important role in the initial partial control of infection.
DISCUSSION
Shortly after infectious challenges, specific host adaptive immune responses are initiated to combat these pathological threats. Most pathogens are effectively contained and then eliminated from the host by these responses; in some cases, however, the infectious agent is only partially controlled and is not eradicated, resulting in long-term persistent infections, immune hyperactivation, and immune-mediated tissue damage [20] . Understanding why the immune system fails to control these infectious pathogens is of great interest, particularly for persistent viral infections that result in high morbidity and mortality, such as infection with hepatitis C virus and HIV. Here, we provide evidence that one mechanism for lentiviral persistence may be a massive immunosuppressive regulatory response induced by the host shortly after viral exposure in secondary lymphatic tissues in response to corresponding viral replication and immune activation.
There is a growing body of evidence that T reg cells suppress effector immune responses by a variety of mechanisms [8, 9, 15, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . In addition, it has recently been shown that T reg cells not only regulate herpes simplex virus-specific CTL responses but may also suppress HIV-specific T cell responses during chronic infection, thus diminishing the magnitude of the immune response to these viral pathogens [8, [32] [33] [34] [35] [36] [37] [38] . Recently, Haeryfar et al. [39] showed that depleting T reg cells significantly enhanced the magnitude of the CTL response to influenza A virus-, vaccinia virus-, and simian virus 40-transformed cells in vivo. These and our present data support a role for T reg cells in controlling the magnitude of CTL responses in vivo, likely through inhibiting T cell proliferation and clonal expansion. To add to the growing evidence for control of pathogenic immune responses by T reg cells, we show here for the first time that, during acute SIV infection, the magnitude of the SIVspecific CTL response to the Tat immunodominant epitope SL8 is inversely related to the magnitude of the immunosuppressive T reg cell response. In addition, preliminary results indicate that RMs with high frequencies of T reg cells in secondary lymphatic tissues have significantly lower frequencies of both IFN-g + cells and IL-12 + cells, compared with those in RMs with low frequencies of T reg cells (authors' unpublished data). Furthermore, the present study indicates that the anatomical distribution of T reg cells in vivo is primarily contained within the paracortical T cell zones of secondary lymphatic tissue, the immune inductive site for the stimulation and activation of effector T cell responses.
Our data suggest that the early, sustained immunosuppressive response is composed, in large part, of TGF-b1 + T reg cells. In the SIV-infected RM model, there are currently no experimental approaches to show in tissue that the initial T reg cell response is antigen specific, as has been shown both in vitro and in vivo in other systems [15, 16, 40, 41 ], but we reason that the early T reg cell response generated shortly after SIV exposure is a consequence of immune activation of resident SIV-specific T reg cells in secondary lymphatic tissue. However, it is likely that, by the peak of this T reg cell response, the production of immunosuppressive effector cytokines (such as TGFb1) by antigen-specific T reg cells may drive the induction of nonspecific inducible "bystander" T reg cells, further amplifying the immunosuppressive response.
What The induction of T reg cells during acute SIV infection likely parallels the induction of immune activation in the paracortical T cell zones of secondary lymphatic tissue as a response by the host to control immune-mediated pathological damage due to immune hyperactivation. However, this T reg cell response dose not appear to be capable of limiting the massive hyperactivation in the lymphatic compartments during acute SIV infection in RMs. In contrast, a recent study by Kornfeld et al. indicates that, during the course of natural infection in African green monkeys (AGMs) infected with SIV agm , a very rapid immunosuppressive response is induced and peaks during the first week of infection, followed by a decease to baseline levels [48] . The much more rapid immunosuppressive response in AGMs abrogates immune hyperactivation, resulting in a far more benign disease outcome in comparison with that in RMs. Thus, the timing of the T reg cell response in relation to immune activation and the adaptive immune response is the critical determinant of outcome. The T reg cell response in SIV-infected RMs is too late to counterbalance and prevent the immunopathological consequences of sustained immune activation and is too early and untimely with respect to immune control, as it down-regulates important effector T cell responses before immune control is achieved. In AGMs, the T reg cell response is also too early to prevent a persistent infection, with viral replication at levels comparable with those in SIV-infected RMs, but is sufficiently early to prevent the immunopathological effects of sustained immune activation.
In summary, we have shown that SIV infection elicits an early T reg cell response in secondary lymphatic tissue, one likely driven by the immune activation associated with infection. Although this immunosuppressive response may limit the immunopathological effects of sustained immune activation and inflammation, the T reg cell response may also limit SIV-specific immune responses at just the time when they are critically needed to clear an infection. We think that a successful vaccine will need to establish a better balance between these beneficial and adverse effects of T reg cell responses, and we speculate that there may be a role for anti-inflammatory treatment during acute infection, to moderate the T reg cell response. 
